Myokardia Inc to Post FY2019 Earnings of ($4.58) Per Share, Wedbush Forecasts (NASDAQ:MYOK)



  • Summary:

     

    Myokardia Inc (NASDAQ:MYOK) – Equities research analysts at Wedbush increased their FY2019 earnings estimates for Myokardia in a research report issued on Thursday, November 7th, Zacks Investment Research reports. Wedbush analyst D. Nierengarten now anticipates that the biotechnology company will post earnings of ($4.58) per share for the year, up from their prior forecast of ($5.50). Wedbush currently has a “Outperform” rating and a $90.00 target price on the stock. Wedbush also issued estimates for Myokardia’s Q4 2019 earnings at ($1.48) EPS, Q1 2020 earnings at ($1.55) EPS, Q2 2020 earnings at ($1.62) EPS, Q3 2020 earnings at ($1.47) EPS, Q4 2020 earnings at ($1.45) EPS, FY2020 earnings at ($6.08) EPS, FY2021 earnings at ($5.00) EPS, FY2022 earnings at ($0.57) EPS and FY2023 earning ...

     

     

    Read Full News: https://trentdailytimes.com/2019/12/04/fy2019-eps-estimates-for-myokardia-inc-nasdaqmyok-boosted-by-wedbush-updated-updated-updated.html


Log in to reply